Galectin Therapeutics, Inc. (GALT)
3.90
+0.14
(+3.72%)
USD |
NASDAQ |
Oct 02, 16:00
3.85
-0.05
(-1.28%)
After-Hours: 20:00
Galectin Therapeutics Price : 3.90 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 3.82 | 3.94 | 3.75 | 3.90 | 220511.0 |
| Oct 01, 2026 | 3.87 | 4.055 | 3.68 | 3.76 | 327425.0 |
| Sep 30, 2026 | 3.90 | 4.05 | 3.824 | 3.88 | 198083.0 |
| Sep 29, 2026 | 3.94 | 4.00 | 3.90 | 3.91 | 174410.0 |
| Sep 28, 2026 | 3.86 | 3.99 | 3.80 | 3.93 | 168755.0 |
| Sep 25, 2026 | 3.93 | 3.99 | 3.86 | 3.90 | 124617.0 |
| Sep 24, 2026 | 4.00 | 4.040 | 3.780 | 3.96 | 153324.0 |
| Sep 23, 2026 | 4.12 | 4.15 | 4.00 | 4.05 | 174131.0 |
| Sep 22, 2026 | 4.05 | 4.24 | 4.050 | 4.14 | 258069.0 |
| Sep 21, 2026 | 3.91 | 4.02 | 3.85 | 3.96 | 258378.0 |
| Sep 18, 2026 | 3.71 | 3.92 | 3.68 | 3.89 | 1.066M |
| Sep 17, 2026 | 3.73 | 3.79 | 3.69 | 3.71 | 171131.0 |
| Sep 16, 2026 | 3.71 | 3.80 | 3.611 | 3.68 | 276068.0 |
| Sep 15, 2026 | 3.82 | 3.825 | 3.580 | 3.73 | 327233.0 |
| Sep 14, 2026 | 3.95 | 4.09 | 3.82 | 3.84 | 338530.0 |
| Sep 11, 2026 | 3.92 | 4.01 | 3.84 | 3.91 | 243766.0 |
| Sep 10, 2026 | 4.00 | 4.050 | 3.84 | 3.90 | 253047.0 |
| Sep 09, 2026 | 4.13 | 4.34 | 4.035 | 4.05 | 515691.0 |
| Sep 08, 2026 | 4.60 | 4.65 | 4.10 | 4.14 | 393417.0 |
| Sep 04, 2026 | 4.33 | 4.72 | 4.33 | 4.61 | 473554.0 |
| Sep 03, 2026 | 4.50 | 4.60 | 4.224 | 4.35 | 244150.0 |
| Sep 02, 2026 | 4.19 | 4.53 | 4.19 | 4.48 | 460696.0 |
| Sep 01, 2026 | 3.91 | 4.385 | 3.91 | 4.17 | 479583.0 |
| Aug 31, 2026 | 4.02 | 4.05 | 3.91 | 3.95 | 229714.0 |
| Aug 28, 2026 | 4.14 | 4.20 | 3.95 | 4.02 | 271187.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Mirum Pharmaceuticals, Inc. | 82.93 |
| ACADIA Pharmaceuticals, Inc. | 19.95 |
| Alnylam Pharmaceuticals, Inc. | 219.72 |
| Savara, Inc. | 4.81 |
| Vericel Corp. | 40.15 |
Price Related Metrics
| Earnings Yield | -11.02% |
| Market Cap | 258.62M |